Paper36914921
Integrated transcriptomics and metabolomics analysis reveals the biomolecular mechanisms associated to the antitumoral potential of a novel silver-based core@shell nanosystem.
Aragoneses-Cazorla G and 4 others. Mikrochim Acta, 2023. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. Integrated transcriptomics and metabolomics analysis reveals the biomolecular mechanisms associated to the antitumoral potential of a novel silver-based core@shell nanosystem. Papers, record 36914921. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36914921
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Integrated transcriptomics and metabolomics analysis reveals the biomolecular mechanisms associated to the antitumoral potential of a novel silver-based core@shell nanosystem.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Nanoparticles | Major topic |
| Silver | Major topic |
| Antineoplastic Agents | Major topic |
| Metabolomics | |
| Transcriptome | |
| Transferrin |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| PID2020-114529RB-I00 | Ministerio de Ciencia e Innovación | PubMed | ||
| PID2020-117091RB-I00 | Ministerio de Ciencia e Innovación | PubMed | ||
| ERC-2015-AdG (VERDI) | H2020 European Research Council | PubMed |
Source PubMed
References88
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35642539 | Engineering mesoporous silica nanoparticles for drug delivery: where are we after two decades? | Chem Soc Rev | 2022 | https://conductscience.org/library/papers/35642539 | PubMed |
| 2 | 24797434 | Glutaminase 2 negatively regulates the PI3K/AKT signaling and shows tumor suppression activity in human hepatocellular carcinoma. | Oncotarget | 2014 | https://conductscience.org/library/papers/24797434 | PubMed |
| 3 | 19207680 | Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes. | J Gastroenterol Hepatol | 2009 | https://conductscience.org/library/papers/19207680 | PubMed |
| 4 | 32873793 | GLUT3 induced by AMPK/CREB1 axis is key for withstanding energy stress and augments the efficacy of current colorectal cancer therapies. | Signal Transduct Target Ther | 2020 | https://conductscience.org/library/papers/32873793 | PubMed |
| 5 | 31546918 | Hyperglycemia Associated Metabolic and Molecular Alterations in Cancer Risk, Progression, Treatment, and Mortality. | Cancers (Basel) | 2019 | https://conductscience.org/library/papers/31546918 | PubMed |
| 6 | 26545398 | Integration of Metabolomics and Transcriptomics Reveals Major Metabolic Pathways and Potential Biomarker Involved in Prostate Cancer. | Mol Cell Proteomics | 2016 | https://conductscience.org/library/papers/26545398 | PubMed |
| 7 | 23242140 | Serine starvation induces stress and p53-dependent metabolic remodelling in cancer cells. | Nature | 2013 | https://conductscience.org/library/papers/23242140 | PubMed |
| 8 | 27919945 | The Leloir Pathway of Galactose Metabolism - A Novel Therapeutic Target for Hepatocellular Carcinoma. | Anticancer Res | 2016 | https://conductscience.org/library/papers/27919945 | PubMed |
| 9 | 32272541 | The Effect of Pantothenic Acid Deficiency on Keratinocyte Proliferation and the Synthesis of Keratinocyte Growth Factor and Collagen in Fibroblasts. | J Pharmacol Sci | 2011 | https://conductscience.org/library/papers/32272541 | PubMed |
| 10 | 21874297 | Mitochondrial ATP synthase: architecture, function and pathology. | J Inherit Metab Dis | 2012 | https://conductscience.org/library/papers/21874297 | PubMed |
| 11 | 30375486 | Functional Variant in the GCKR Gene Affects Lactate Levels Differentially in the Fasting State and During Hyperglycemia. | Sci Rep | 2018 | https://conductscience.org/library/papers/30375486 | PubMed |
| 12 | 30122555 | Cytosolic Aspartate Availability Determines Cell Survival When Glutamine Is Limiting. | Cell Metab | 2018 | https://conductscience.org/library/papers/30122555 | PubMed |
| 13 | 27458133 | The importance of serine metabolism in cancer. | J Cell Biol | 2016 | https://conductscience.org/library/papers/27458133 | PubMed |
| 14 | 28923859 | Upregulation of Cystathionine-β-Synthase in Colonic Epithelia Reprograms Metabolism and Promotes Carcinogenesis. | Cancer Res | 2017 | https://conductscience.org/library/papers/28923859 | PubMed |
| 15 | 28440458 | Role of the cystathionine β-synthase/H2S system in liver cancer cells and the inhibitory effect of quinolone-indolone conjugate QIC2 on the system. | Oncol Rep | 2017 | https://conductscience.org/library/papers/28440458 | PubMed |
| 16 | 25175369 | Downregulation of phosphoglycerate kinase 1 by shRNA sensitizes U251 xenografts to radiotherapy. | Oncol Rep | 2014 | https://conductscience.org/library/papers/25175369 | PubMed |
| 17 | 25115398 | Fructose-2,6-bisphosphate synthesis by 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4 (PFKFB4) is required for the glycolytic response to hypoxia and tumor growth. | Oncotarget | 2014 | https://conductscience.org/library/papers/25115398 | PubMed |
| 18 | 23764751 | Asparagine synthetase is an independent predictor of surgical survival and a potential therapeutic target in hepatocellular carcinoma. | Br J Cancer | 2013 | https://conductscience.org/library/papers/23764751 | PubMed |
| 19 | 26979502 | Metabolomics: beyond biomarkers and towards mechanisms. | Nat Rev Mol Cell Biol | 2016 | https://conductscience.org/library/papers/26979502 | PubMed |
| 20 | 30530489 | Lysine methylation by the mitochondrial methyltransferase FAM173B optimizes the function of mitochondrial ATP synthase. | J Biol Chem | 2019 | https://conductscience.org/library/papers/30530489 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42654036 | Systems-Level Multi-Omics Analysis Resolves the Mechanism of Action of a Novel Multifunctional Nanosystem Against Triple-Negative Breast Cancer. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42654036 | PubMed |
| 41345166 | Integrative metabolomic and transcriptomic analyses reveal flavonoid biosynthesis pathway in Eupatorium lindleyanum. | Sci Rep | 2025 | https://conductscience.org/library/papers/41345166 | PubMed |
| 39610791 | In vitro β-catenin attenuation by a mefloquine-loaded core-shell nano emulsion strategy to suppress liver cancer cells. | Nanoscale Adv | 2025 | https://conductscience.org/library/papers/39610791 | PubMed |
Genes42
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36914921
GET https://conductscience.org/api/papers/v1/36914921/references?page=2